OncoSoft, a medical artificial intelligence (AI) company, provided consulting on its major products, including OncoStudio, an AI medical image contouring solution for radiation therapy planning, and presented research results on the medical application of Large Language Models (LLMs) at the '24 Medical Particle Radiotherapy Joint Workshop held at the Asti Hotel in Busan from February 23rd to 24th.
Jin Sung Kim, CEO of Oncosoft, presented Oncosoft's technology direction in the medical AI market and shared its core technologies and achievements.
He presented a vision of extracting and integrating medical information using LLM ⦁ chatGPT models from various clinical data such as clinical notes, as well as medical information detected by AI technology from existing CT image data, and expanding the portfolio with Oncosoft's AI solutions.
Oncosoft is a company that supports <medical AI treatment solutions> beyond medical AI diagnosis, and after acquiring the medical device license from the Ministry of Food and Drug Administration in February 22, OncoStudio has been working on developing various AI software throughout the radiation treatment process for cancer patients.
